LDHC and breast carcinoma: We previously demonstrated the aberrant expression of LDHC in breast tumor tissues of the TCGA breast cancer dataset, in particular in basal-like and Her2-enriched breast tumors, which was associated with worse overall and disease-specific survival [11].